Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Small Cell Lung Carcinoma × Vorinostat × 30 days × Clear all

Sponsor

Conditions

Myelodysplastic Syndromes 2 Leukemia, Myelomonocytic, Chronic 2 Anemia, Refractory, with Excess of Blasts 2 Uveal Melanoma 1 Recurrence 1 Oligodendroglioma 1 Neuroblastoma 1 Neoplasm Metastasis 1 Lymphoma, Extranodal NK-T-Cell 1 Leukemia, Myeloid, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 GATA2 Deficiency 1 Breast Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1 Anemia, Refractory 1

Interventions

Etoposide 11 Carboplatin 11 durvalumab 8 PM 01183 8 atezolizumab 6 pembrolizumab 5 Topotecan 5 Specimen Handling 4 Paclitaxel 4 Nivolumab 4 Radiosurgery 3 Ipilimumab 3 Drug Therapy 3 Bevacizumab 3 AMG 757 3 cabozantinib 2 berzosertib 2 Temozolomide 2 Radiotherapy 2 Magnetic Resonance Spectroscopy 2 Biopsy 2 tremelimumab 1 trastuzumab deruxtecan 1 toripalimab 1 tazemetostat 1 talazoparib 1 surufatinib 1 stenoparib 1 sacituzumab govitecan 1 regorafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡